freyrsolutionsm

ISO 13485:2016 is a specialized QMS standard that ensures consistent regulatory compliance in the medical device industry. Its adoption into ISO 13485:2016 US regulations highlights a major regulatory evolution toward global best practices. Understanding ISO 13485:2016 The standard governs design, production, and post-market activities, emphasizing risk management and continuous improvement, ensuring effective ISO 13485 FDA compliance . Regulatory Integration The ISO 13485 incorporation into US FDA introduces the Quality Management System Regulation (QMSR), replacing traditional QSR and aligning with FDA QMSR ISO 13485 principles. Key Changes Enhanced documentation practices Lifecycle risk integration Stronger supplier management Benefits Improved safety and quality outcomes Simplified compliance across regions Greater global acceptance Operational efficiency Challenges Implementation requires cultural change, finan...

  The convergence of healthcare and advanced technology has significantly reshaped how medical interventions are designed, delivered, and monitored. At the core of this evolution is Software as a Medical Device (SaMD) , which performs medical functions independently of any associated hardware device. Unlike traditional SaMD global registration , which is embedded within a physical product, SaMD functions autonomously across cloud environments, mobile platforms, and clinical decision-support systems. It enables diagnostic algorithms, remote monitoring, digital therapeutics, and AI-driven decision support, all powered by strong data pipelines and advanced analytics. As the ecosystem evolves, global authorities are accelerating efforts to define Software as a Medical Device regulation , harmonize expectations, and ensure patient safety, cybersecurity, data integrity, and performance. For manufacturers, navigating SaMD regulatory requirements while building scalable strategies for...

  The EU MDR has fundamentally changed MDR clinical evaluation by moving from a document-focused approach to a lifecycle-based, evidence-driven framework. Under the MDD, manufacturers often depended on static CERs, literature summaries, and equivalence claims without regular updates. Under MDR, clinical evaluation must be continuously planned, systematic, and transparent. It must confirm that a device’s safety and clinical performance remain acceptable when compared to the current state of the art, supported by solid clinical data. Understanding how to prepare clinical evaluation report CER under MDR is essential. EU MDR 2017/745 requires manufacturers to follow Articles 61 and Annex XIV, ensuring that clinical evaluation is ongoing and evidence-based. Manufacturers must demonstrate: Intended clinical performance achievement Data-supported clinical benefits Acceptable and minimized risks Continuous evidence validity A CER is no longer a stati...